Everest Group, Ltd.

Equities

EG

BMG3223R1088

Reinsurance

Real-time Estimate Cboe BZX 12:20:21 2024-07-11 pm EDT 5-day change 1st Jan Change
380.1 USD +0.52% Intraday chart for Everest Group, Ltd. +4.53% +7.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
BofA Securities Adjusts Price Target on Everest to $493 From $470, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Everest to $392 From $395, Equalweight Rating Maintained MT
Jefferies Adjusts Price Target on Everest to $455 From $461 MT
Morgan Stanley Adjusts Price Target on Everest to $445 From $450 MT
Keefe Bruyette & Woods Adjusts Everest Group's Price Target to $457 From $458, Keeps Outperform Rating MT
India's Rajasthan starts recalling some batches of MDH, Everest spices RE
India's Rajasthan finds some MDH and Everest spices unsafe for consumption RE
India's Rajasthan finds some MDH and Everest spices unsafe for consumption RE
Indian climber rescued from Everest dies in hospital as season closes RE
Everest Metals Completes Drilling at Mt Edon Project MT
Sherpa scales Mount Everest for record 30th time RE
Autonomous Adjusts Price Target on Everest Group to $380 From $370 MT
Paramount Global, Lion Star, Everest Place Plan to Open Nickelodeon Hotels & Resorts Orlando in 2026 MT
Nepal sherpa scales Everest for record 30th time; two climbers go missing RE
Indian spice trade group fears plunge in exports due to ETO pesticide scrutiny RE
Mongolian climber dies in season's first Everest fatality RE
UK tightens scrutiny of all Indian spice imports amid contamination allegations RE
Everest Group Raises Quarterly Dividend to $2 a Share From $1.75, Payable June 14 to Shareholders of Record May 29 MT
Everest Group, Ltd. Declares Quarterly Dividend, Payable on or Before June 14, 2024 CI
New Zealand looking into Indian spice brands over contamination RE
Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise MT
Everest Medicines Commercially Launches Kidney Disease Drug in China MT
Who are the two iconic Indian spice brands under scrutiny? RE
UK mountaineer logs most Everest climbs by a foreigner, Nepali makes 29th ascent RE
Everest Group Insider Sold Shares Worth $380,490, According to a Recent SEC Filing MT
Chart Everest Group, Ltd.
More charts
Everest Group, Ltd. is a reinsurance group organized around 2 areas of activity: - non-life reinsurance (68.9% of gross written premiums): real estate, damage, health, accidents, maritime reinsurance, etc.; - insurance (31.1%): real estate and casualty insurance.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
378.2 USD
Average target price
427 USD
Spread / Average Target
+12.92%
Consensus
  1. Stock Market
  2. Equities
  3. EG Stock
  4. News Everest Group, Ltd.
  5. Everest Foresees Surge in 2023 Revenue